Loading data
PAVSNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 14.6 m USD | 71.54 k USD | 0 USD | 0 USD | 20.76 m USD |
| Cost of revenue | 12.19 m USD | 62.53 k USD | 0 USD | 0 USD | 20.5 m USD |
| Gross profit | 2.41 m USD | 9.02 k USD | 0 USD | 0 USD | 257.26 k USD |
| Research and development expense | — | — | — | 1.4 m USD | 1.68 m USD |
| Operating profit | -14.66 m USD | -6.78 m USD | -4.27 m USD | -4 m USD | -11.17 m USD |
| Interest expense | 262.51 k USD | 261.85 k USD | 39.17 k USD | 0 USD | 0 USD |
| Profit before tax | -14.48 m USD | -7 m USD | -4.29 m USD | -4.28 m USD | -10.2 m USD |
| Income tax expense | 1.24 m USD | 0 USD | 0 USD | 0 USD | 696 USD |
| Net income (reported basis) | -12.73 m USD | -7.89 m USD | -10.13 m USD | -71.74 m USD | -48.8 m USD |
| Net income attributable to common shareholders | -15.72 m USD | -7 m USD | -4.09 m USD | — | — |
| Basic earnings per share | — | — | — | -12.63 USD/share | -1.22 USD/share |
| Diluted earnings per share | -8,485 USD/share | -11,208 USD/share | -256,753 USD/share | -12.63 USD/share | -1.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.